---
$id: https://graph.org.ai/products/commodity/51313404
$type: Product
source: UNSPSC
code: "51313404"
title: "Brompheniramine"
class: "51313400"
classTitle: "Antihistamine or H1 blocker pyridines"
family: "51310000"
familyTitle: "Antihistamines or H1 blockers"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Brompheniramine

**UNSPSC Code**: 51313404
**Class**: [Antihistamine or H1 blocker pyridines](Antihistamine or H1 blocker pyridines.mdx)
**Family**: [Antihistamines or H1 blockers](../Antihistamines or H1 blockers.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H19BrN2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H57G17P2FN, chemically known as 3-(p-bromophenyl)-3-(2-pyridyl)-n,n-dimethylpropylamine but generally known as brompheniramine, which bears US NIH Compound Identifier 6834. Brompheniramine most often comes in base and maleate forms. European Medicines Agency schedules Brompheniramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05924MIG. The term BROMPHENIRAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules brompheniramine in its Anatomical Therapeutic Chemical (ATC) Classification. BROMPHENIRAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule brompheniramine under HS 29333999 and SITC 51574. As of Q4 2014, BROMPHENIRAMINE remains the US FDA Preferred Term for this commodity. Brompheniramine bears US NLM identifiers UMLS ID C0006246 and NCI Concept Code C61655. SMILES: BRC1CCC(C(CCN(C)C)C2NCCCC2)CC1.

